Investor Relations

KPJ Healthcare Berhad (KPJ) is one of the leading private healthcare providers in the region with a network of 29 hospitals in Malaysia, 1 hospital in Thailand, 1 hospital in Bangladesh and 4 retirement and aged care facilities in Kuala Lumpur, Sibu, Pahang and in Brisbane, Australia. With more than 3,500 operating beds, KPJ hospitals offer a comprehensive range of specialist medical services that treated more than 3 million patients in 2022.

Bursa Announcements

Changes In Sub. S-hldr's Int (Section 138 Of CA 2016) - Employees Provident Fund

BackJul 04, 2018

Particulars of substantial Securities Holder

Name	EMPLOYEES PROVIDENT FUND
Address	Tingkat 19 Bangunan KWSP Jalan Raja Laut Kuala Lumpur 50350 Wilayah Persekutuan Malaysia.
Company No.	EPF ACT 1991
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary shares

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	29 Jun 2018	150,000	Disposed	Indirect Interest
	Name of registered holder	Citigroup Nominees (Tempatan) Sdn Bhd, Employees Provident Fund Board
	Address of registered holder	Level 42, Menara Citibank 165 Jalan Ampang 50450 Kuala Lumpur
	Description of "Others" Type of Transaction
2	29 Jun 2018	464,100	Acquired	Indirect Interest
	Name of registered holder	Citigroup Nominees (Tempatan) Sdn Bhd Employees Fund Board (Asian Islamic) IC
	Address of registered holder	Level 42, Menara Citibank, 165 Jalan Ampang, 50450 Kuala Lumpur
	Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred	Acquired & Disposed
Nature of interest	Indirect Interest
Direct (units)
Direct (%)
Indirect/deemed interest (units)
Indirect/deemed interest (%)
Total no of securities after change	523,143,580
Date of notice	02 Jul 2018
Date notice received by Listed Issuer	04 Jul 2018

Remarks :

The Notice of Change was received on 4 July 2018 via courier.

Announcement Info

Company Name	KPJ HEALTHCARE BERHAD
Stock Name	KPJ
Date Announced	04 Jul 2018
Category	Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016
Reference Number	CS2-04072018-00044